Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Abstract
The nuclear factor-kappaB (NF-κB) signaling pathway is considered as a potential therapeutic target in cancer therapy. It has been well established that transcription factor NF-κB is involved in regulating physiological and pathological events including inflammation, immune response and differentiation. Increasing evidences suggest that deregulated NF-κB signaling can enhance cancer cell proliferation, metastasis and also mediate radio-as well as chemo-resistance. On the contrary, non-coding RNAs (ncRNAs) have been found to modulate NF-κB signaling pathway under different settings. MicroRNAs (miRNAs) can dually inhibit/induce NF-κB signaling thereby affecting the growth and migration of cancer cells. Furthermore, the response of cancer cells to radiotherapy and chemotherapy may also be regulated by miRNAs. Regulation of NF-κB by miRNAs may be mediated via binding to 3/-UTR region. Interestingly, anti-tumor compounds can increase the expression of tumor-suppressor miRNAs in inhibiting NF-κB activation and the progression of cancers. Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) can also effectively modulate NF-κB signaling thus affecting tumorigenesis. Noteworthy, several studies demonstrate that lncRNAs and circRNAs can affect miRNAs in targeting NF-κB activate. They can act as competing endogenous RNA (ceRNA) thereby reducing miRNA expression to induce NF-κB activation that can enhance cancer progression and malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
9 retracted
Huang, Y., Zhang, J., Hou, L., Wang, G., Liu, H., Zhang, R., Chen, X., & Zhu, J. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0666-2 · Cited by 205
RetractedDong, H., Wang, W., Mo, S., Chen, R., Zou, K., Han, J., Zhang, F., & Hu, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0875-3 · Cited by 161
RetractedZhang, J., Chen, Z.-H., Chen, D.-L., Tian, X.-P., Wang, C.-Y., Zhou, Z.-W., Gao, Y., Xu, Y., Chen, C., Zheng, Z.-S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0162-y · Cited by 140
RetractedMotiwala, T., Kutay, H., Ghoshal, K., Bai, S., Seimiya, H., Tsuruo, T., Suster, S. M., Morrison, C., & Jacob, S. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405451101 · Cited by 111
RetractedDuan, M., Fang, M., Wang, C., Wang, H., & Li, M. (2020) · Cancer Management and Research · doi:10.2147/cmar.s229013 · Cited by 69
RetractedMiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-κB pathway
Ruan, L., & Qian, X. (2019) · Bioscience Reports · doi:10.1042/bsr20191611 · Cited by 63
RetractedChen, T., Yu, Q., Lei, X., & Guo, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29296 · Cited by 40
RetractedKong, D., Zhang, D., Chu, X., & Wang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.035 · Cited by 33
RetractedChen, Y., Lei, Y., Lin, J., Huang, Y., Zhang, J., Chen, K., Sun, S., & Lin, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s253730 · Cited by 6
RetractedIsolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Functional Classification and Experimental Dissection of Long Noncoding RNAs
Kopp, F., & Mendell, J. T. (2018) · Cell · doi:10.1016/j.cell.2018.01.011 · Cited by 3,529
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Sanger, H. L., Klotz, G., Riesner, D., Gross, H. J., & Kleinschmidt, A. K. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3852 · Cited by 2,296
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Zhang, Q., Lenardo, M. J., & Baltimore, D. (2017) · Cell · doi:10.1016/j.cell.2016.12.012 · Cited by 1,982
The non-canonical NF-κB pathway in immunity and inflammation
Sun, S.-C. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.52 · Cited by 1,891
Mu, J., Wang, G., Yan, H., Li, H., Wang, X., Gao, E., Hou, C., Pham, A. T. C., Wu, L., Zhang, Q., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03032-2 · Cited by 1,436
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
Fang, T., Lv, H., Lv, G., Li, T., Wang, C., Han, Q., Yu, L., Su, B., Guo, L., Huang, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02583-0 · Cited by 995
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
Deubiquitination and Stabilization of PD-L1 by CSN5
Lim, S.-O., Li, C.-W., Xia, W., Cha, J.-H., Chan, L.-C., Wu, Y., Chang, S.-S., Lin, W.-C., Hsu, J.-M., Hsu, Y.-H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.010 · Cited by 793
Exosome mediated communication within the tumor microenvironment
Milane, L., Singh, A., Mattheolabakis, G., Suresh, M., & Amiji, M. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.029 · Cited by 742
Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., & Chiao, P. J. (1999) · PubMed · Cited by 726
The noncanonical NF‐κB pathway
Sun, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01088.x · Cited by 722
Distinct molecular mechanism for initiating TRAF6 signalling
Ye, H., Arron, J. R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N. K., Segal, D., Dzivenu, O. K., Vologodskaia, M., Yim, M., et al. (2002) · Nature · doi:10.1038/nature00888 · Cited by 662
Functions of NF-κB1 and NF-κB2 in immune cell biology
BEINKE, S., & LEY, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040544 · Cited by 610
De Simone, V, Franzè, E., Ronchetti, G., Colantoni, A., Fantini, M. C., Di Fusco, D., Sica, G. S., Sileri, P., MacDonald, T. T., Pallone, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.286 · Cited by 595
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489
Zheng, X., Huang, M., Xing, L., Yang, R., Wang, X., Jiang, R., Zhang, L., & Chen, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01183-9 · Cited by 456
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
Huang, D., Chen, J., Yang, L., Ouyang, Q., Li, J., Lao, L., Zhao, J., Liu, J., Lu, Y., Xing, Y., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0207-y · Cited by 448
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Wong, C.-M., Tsang, F. H.-C., & Ng, I. O.-L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.169 · Cited by 424
CircRNA: a rising star in gastric cancer
Li, R., Jiang, J., Shi, H., Qian, H., Zhang, X., & Xu, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03345-5 · Cited by 418
Capece, D., Fischietti, M., Verzella, D., Gaggiano, A., Cicciarelli, G., Tessitore, A., Zazzeroni, F., & Alesse, E. (2013) · BioMed Research International · doi:10.1155/2013/187204 · Cited by 408
Weinfurt, K. P., Li, Y., Castel, L. D., Saad, F., Timbie, J. W., Glendenning, G. A., & Schulman, K. A. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi122 · Cited by 362
Targeting autophagy using natural compounds for cancer prevention and therapy
Deng, S., Shanmugam, M. K., Kumar, A. P., Yap, C. T., Sethi, G., & Bishayee, A. (2019) · Cancer · doi:10.1002/cncr.31978 · Cited by 320
Self-citationNagahashi, M., Ramachandran, S., Kim, E. Y., Allegood, J. C., Rashid, O. M., Yamada, A., Zhao, R., Milstien, S., Zhou, H., Spiegel, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2167 · Cited by 315
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Self-citationNoncanonical NF-κB Signaling in Health and Disease
Cildir, G., Low, K. C., & Tergaonkar, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.002 · Cited by 301
Self-citationRole for sphingosine kinase 1 in colon carcinogenesis
Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., & Obeid, L. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-117572 · Cited by 280
Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression
Liang, G., Ling, Y., Mehrpour, M., Saw, P. E., Liu, Z., Tan, W., Tian, Z., Zhong, W., Lin, W., Luo, Q., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01152-2 · Cited by 260
Ren, D., Yang, Q., Dai, Y., Guo, W., Du, H., Song, L., & Peng, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0688-6 · Cited by 233
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
Mishra, S., Verma, S. S., Rai, V., Awasthee, N., Chava, S., Hui, K. M., Kumar, A. P., Challagundla, K. B., Sethi, G., & Gupta, S. C. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03053-0 · Cited by 226
Self-citationYe, H., Zhou, Q., Zheng, S., Li, G., Lin, Q., Wei, L., Fu, Z., Zhang, B., Liu, Y., Li, Z., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0486-0 · Cited by 216
Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13)
Panagopoulos, I. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.395 · Cited by 214
Small Molecule NF-κB Pathway Inhibitors in Clinic
Ramadass, V., Vaiyapuri, T., & Tergaonkar, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145164 · Cited by 210
Self-citationNon-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
Li, Y., Zhou, Q.-L., Sun, W., Chandrasekharan, P., Cheng, H. S., Ying, Z., Lakshmanan, M., Raju, A., Tenen, D. G., Cheng, S.-Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3240 · Cited by 200
Self-citationAsgarova, A., Asgarov, K., Godet, Y., Peixoto, P., Nadaradjane, A., Boyer-Guittaut, M., Galaine, J., Guenat, D., Mougey, V., Perrard, J., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1423170 · Cited by 199
Li, F., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1470-4 · Cited by 198
Self-citationChen, X., Pan, X., Zhang, W., Guo, H., Cheng, S., He, Q., Yang, B., & Ding, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.09.006 · Cited by 197
Puar, Y., Shanmugam, M., Fan, L., Arfuso, F., Sethi, G., & Tergaonkar, V. (2018) · Biomedicines · doi:10.3390/biomedicines6030082 · Cited by 197
Self-citationLong Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
Xu, J., Meng, Q., Li, X., Yang, H., Xu, J., Gao, N., Sun, H., Wu, S., Familiari, G., Relucenti, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3880 · Cited by 196
Roles of NF-κB in health and disease: mechanisms and therapeutic potential
Wong, E. T., & Tergaonkar, V. (2009) · Clinical Science · doi:10.1042/cs20080502 · Cited by 196
Self-citationNoncoding RNAs: Master Regulators of Inflammatory Signaling
Chew, C. L., Conos, S. A., Unal, B., & Tergaonkar, V. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.11.003 · Cited by 195
Self-citationShang, Z., Yu, J., Sun, L., Tian, J., Zhu, S., Zhang, B., Dong, Q., Jiang, N., Flores-Morales, A., Chang, C., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz108 · Cited by 191
Dai, X., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215579167 · Cited by 189
Self-citationLncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling
Sang, L.-J., Ju, H.-Q., Liu, G.-P., Tian, T., Ma, G.-L., Lu, Y.-X., Liu, Z.-X., Pan, R.-L., Li, R.-H., Piao, H.-L., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.014 · Cited by 183
Kapitonov, D., Allegood, J. C., Mitchell, C., Hait, N. C., Almenara, J. A., Adams, J. K., Zipkin, R. E., Dent, P., Kordula, T., Milstien, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0664 · Cited by 182
Li, F., Shanmugam, M. K., Chen, L., Chatterjee, S., Basha, J., Kumar, A. P., Kundu, T. K., & Sethi, G. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0070 · Cited by 180
Self-citationHu, Y.-P., Jin, Y.-P., Wu, X.-S., Yang, Y., Li, Y.-S., Li, H.-F., Xiang, S.-S., Song, X.-L., Jiang, L., Zhang, Y.-J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1097-9 · Cited by 180
Hu, N., Wang, C., Dai, X., Zhou, M., Gong, L., Yu, L., Peng, C., & Li, Y. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112361 · Cited by 179
PD-L1 status in breast cancer: Current view and perspectives
Vranić, S., Cyprian, F. S., Gatalica, Z., & Palazzo, J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.003 · Cited by 177
Qureshi-Baig, K., Kuhn, D., Viry, E., Pozdeev, V. I., Schmitz, M., Rodriguez, F., Ullmann, P., Koncina, E., Nurmik, M., Frasquilho, S., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1687213 · Cited by 177
CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers
Kong, T., Ahn, R., Yang, K., Zhu, X., Fu, Z., Morin, G., Bramley, R., Cliffe, N. C., Xue, Y., Kuasne, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1108 · Cited by 175
Cai, H., Yan, L., Liu, N., Xu, M., & Cai, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109790 · Cited by 175
Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition
Cheng, J.-T., Wang, L., Wang, H., Tang, F.-R., Cai, W.-Q., Sethi, G., Xin, H.-W., & Ma, Z. (2019) · Cells · doi:10.3390/cells8101178 · Cited by 172
Self-citationWIP1 phosphatase is a negative regulator of NF-κB signalling
Chew, J., Biswas, S., Shreeram, S., Humaidi, M., Wong, E. T., Dhillion, M. K., Teo, H., Hazra, A., Fang, C. C., López-Collazo, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1873 · Cited by 172
Self-citationLi, J., Wu, H., Li, W., Yin, L., Guo, S., Xu, X., Ouyang, Y., Zhao, Z., Liu, S., Tian, Y., et al. (2016) · Oncogene · doi:10.1038/onc.2016.90 · Cited by 167
The NF-KB pathway and endocrine therapy resistance in breast cancer
Khongthong, P., Roseweir, A. K., & Edwards, J. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0087 · Cited by 164
Meng, Q., Liang, C., Hua, J., Zhang, B., Liu, J., Zhang, Y., Wei, M., Yu, X., Xu, J., & Shi, S. (2020) · Theranostics · doi:10.7150/thno.40566 · Cited by 164
Ong, P. S., Wang, L. Z., Dai, X., Tseng, S. H., Loo, S. J., & Sethi, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00395 · Cited by 162
Self-citationRho protein GTPases and their interactions with NFκB: crossroads of inflammation and matrix biology
Tong, L., & Tergaonkar, V. (2014) · Bioscience Reports · doi:10.1042/bsr20140021 · Cited by 162
Self-citationWang, H., Xiao, Y., Wu, L., & Ma, D. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4265 · Cited by 161
Manu, K. A., Shanmugam, M. K., Li, F., Chen, L., Siveen, K. S., Ahn, K. S., Kumar, A. P., & Sethi, G. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1095-0 · Cited by 160
Self-citationManu, K. A., Shanmugam, M. K., Ramachandran, L., Li, F., Siveen, K. S., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Arfuso, F., Kumar, A. P., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.033 · Cited by 159
Self-citationInflammation and cancer: Breast cancer as a prototype
Mantovani, A., Marchesi, F., Porta, C., Sica, A., & Allavena, P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.013 · Cited by 159
Xie, C., Zhang, L., Chen, Z., Zhong, W., Fang, J., Zhu, Y., Xiao, M., Guo, Z., Zhao, N., He, X., et al. (2020) · Hepatology · doi:10.1002/hep.30931 · Cited by 159
Wang, B., Mao, J., Wang, B.-Y., Wang, L., Wen, H., Xu, L., Fu, J., & Yang, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.038 · Cited by 155
Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation
Akıncılar, S. C., Khattar, E., Boon, P. L. S., Unal, B., Fullwood, M. J., & Tergaonkar, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0177 · Cited by 152
Self-citationDistinct roles of IκB proteins in regulating constitutive NF-κB activity
Tergaonkar, V., Correa, R. G., Ikawa, M., & Verma, I. M. (2005) · Nature Cell Biology · doi:10.1038/ncb1296 · Cited by 152
Self-citationLange, C. A., & Yee, D. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0112 · Cited by 147
Impact of tumor‐associated macrophages on invasive ductal carcinoma of the pancreas head
YOSHIKAWA, K., Mitsunaga, S., Kinoshitá, T., Konishi, M., Takahashi, S., Gotohda, N., Kato, Y., Aizawa, M., & Ochiai, A. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02411.x · Cited by 147
Pandya, G., Kirtonia, A., Sethi, G., Pandey, A. K., & Garg, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188423 · Cited by 141
Self-citationLi, P., Zhang, X., Wang, L., Du, L., Yang, Y., Liu, T., Li, C., & Wang, C. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.07.007 · Cited by 140
Patra, S., Mishra, S. R., Behera, B. P., Mahapatra, K. K., Panigrahi, D. P., Bhol, C. S., Praharaj, P. P., Sethi, G., Patra, S. K., & Bhutia, S. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.008 · Cited by 137
Self-citationAhn, K. S., Sethi, G., Jain, A. K., Jaiswal, A. K., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601162200 · Cited by 134
Self-citationMohan, C. D., Srinivasa, V., Rangappa, S., Mervin, L., Mohan, S., Paricharak, S., Baday, S., Li, F., Shanmugam, M. K., Chinnathambi, A., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153155 · Cited by 130
Self-citationIL-1β/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis
ping, P. H., bo, T. F., Li, L., hui, Y. N., & Zhu, H. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.06.001 · Cited by 130
Wu, W., Chen, F., Cui, X., Yang, L., Chen, J., Zhao, J., Huang, D., Liu, J., Yang, L., Zeng, J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31605 · Cited by 129
Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-κB activation and cell survival
Ghosh, S., Tergaonkar, V., Rothlin, C. V., Correa, R. G., Bottero, V., Bist, P., Verma, I. M., & Hunter, T. R. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.007 · Cited by 128
Self-citationSu, C., Han, Y., Zhang, H., Li, Y., Yi, L., Wang, X., Zhou, S., Yu, D., Song, X., Xiao, N., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13587 · Cited by 127
Targeting TNF for Treatment of Cancer and Autoimmunity
Sethi, G., Sung, B., Kunnumakkara, A. B., & Aggarwal, B. B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_3 · Cited by 126
Self-citationLi, Y., Duo, Y., Bi, J., Zeng, X., Mei, L., Bao, S., He, L., Shan, A., Zhang, Y., & Yu, X. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s158290 · Cited by 124
NF-kB-regulated exosomal miR-155 promotes the inflammation associated with arsenite carcinogenesis
Chen, C., Luo, F., Liu, X., Lu, L., Xu, H., Yang, Q., Xue, J., Shi, L., Li, J., Zhang, A., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.027 · Cited by 122
Qin, W., Li, J., Zhu, R., Gao, S., Fan, J., Xia, M., Zhao, R. C., & Zhang, J. (2019) · Aging · doi:10.18632/aging.102537 · Cited by 120
Li, B., Lü, Y., Yu, L., Han, X., Wang, H., Mao, J., Shen, J., Tang, J., Tang, J., Li, C., et al. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.08.014 · Cited by 120
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Cai, W., Chen, Z. X., Rane, G., Singh, S. S., Choo, Z., Wang, C., Yuan, Y., Tan, T. Z., Arfuso, F., Yap, C. T., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw278 · Cited by 119
Self-citationHuang, S., Wa, Q., Pan, J., Peng, X., Ren, D., Huang, Y., Chen, X., & Tang, Y. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0645-7 · Cited by 118
Li, W., Du, Q., Li, X., Zheng, X., Lv, F., Xi, X., Huang, G., Yang, J., & Liu, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00114 · Cited by 116
Chen, Z., Yu, C., Zhan, L., Pan, Y., Chen, L., & Sun, C. (2016) · PubMed Central · Cited by 114
Zhang, Y., Chiu, S., Liang, X., Gao, F., Zhang, Z., Liao, S.-Y., Liang, Y., Chai, Y.-H., Low, D., Tse, H., et al. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.7 · Cited by 113
Self-citationMan, X., Piao, C., Lin, X., Kong, C., Cui, X., & Jiang, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1262-4 · Cited by 113
TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway
Yang, W., Liu, L., Li, C., Luo, N., Chen, R., Li, L., Yu, F., & Cheng, Z. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0881-6 · Cited by 108
miR-155 as a novel clinical target for hematological malignancies
Witten, L., & Slack, F. J. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz183 · Cited by 107
Feng, C., Zhao, Y., Li, Y., Zhang, T., Ma, Y., & Liu, Y. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.03.018 · Cited by 103
Ren, X., Chen, C., Luo, Y., Liu, M., Li, Y., Zheng, S., Ye, H., Fu, Z., Li, M., Li, Z., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01153-1 · Cited by 102
LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P
You, Z., Liu, C., Wang, C., Ling, Z., Wang, Y., Wang, Y., Zhang, M., Chen, S., Xu, B., Guan, H., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0095 · Cited by 102
Mei, L., Wang, W., Qiu, Y., Xie, X., Bai, J., & Shi, Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091833 · Cited by 99
Liu, H., Wang, J., Tao, Y., Li, X., Qin, J., Bai, Z., Chi, B., Yan, W., & Chen, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.049 · Cited by 98
The transcriptional program, functional heterogeneity, and clinical targeting of mast cells
Cildir, G., Pant, H., Lopez, A. F., & Tergaonkar, V. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170910 · Cited by 98
Self-citationp53 and NF-κB Crosstalk: IKKα Tips the Balance
Tergaonkar, V., & Perkins, N. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.006 · Cited by 97
Self-citationHuang, M., Wang, H., Hu, X., & Cao, X. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1518628 · Cited by 97
Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis
Morgan, D., Garg, M., Tergaonkar, V., Tan, S., & Sethi, G. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188449 · Cited by 96
Self-citationMohan, C. D., Anilkumar, N. C., Rangappa, S., Shanmugam, M. K., Mishra, S., Chinnathambi, A., Alharbi, S. A., Bhattacharjee, A., Sethi, G., Kumar, A. P., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00042 · Cited by 96
Self-citationZebrafish IκB Kinase 1 Negatively Regulates NF-κB Activity
Correa, R. G., Matsui, T., Tergaonkar, V., Rodríguez-Esteban, C., Izpisúa‐Belmonte, J. C., & Verma, I. M. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.023 · Cited by 95
Self-citationThe lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers
Gooding, A. J., Zhang, B., Gunawardane, L. S., Beard, A., Valadkhan, S., & Schiemann, W. P. (2018) · Oncogene · doi:10.1038/s41388-018-0586-4 · Cited by 93
MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4
Li, H., Ouyang, R., Wang, Z., Zhou, W., Chen, H., Jiang, Y., Zhang, Y., Li, H., Liao, M., Wang, W., et al. (2016) · Scientific Reports · doi:10.1038/srep39001 · Cited by 92
Cai, Y., Sukhova, G. K., Wong, H. K., Xu, A., Tergaonkar, V., Vanhoutte, P. M., & Tang, E. H. C. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1100771 · Cited by 92
Self-citationThe expanding roles of long non-coding RNAs in the regulation of cancer stem cells
Ma, Z., Wang, Y., Xin, H.-W., Wang, L., Arfuso, F., Dharmarajan, A., Kumar, A. P., Wang, H., Tang, F. R., Warrier, S. R., et al. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.003 · Cited by 90
Self-citationKansara, S., Pandey, V., Lobie, P. E., Sethi, G., Garg, M., & Pandey, A. K. (2020) · Cells · doi:10.3390/cells9061511 · Cited by 89
Self-citationHaemmig, S., Baumgartner, U., Glück, A., Zbinden, S., Tschan, M. P., Kappeler, A., Mariani, L., Vajtai, I., & Vassella, E. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.245 · Cited by 88
Khori, V., Amani-Shalamzari, S., Isanejad, A., Alizadeh, A. M., Alizadeh, S., Khodayari, S., Khodayari, H., Shahbazi, S., Amiri, A. Z., Sohanaki, H., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.031 · Cited by 87
Zhang, B., Shetti, D., Fan, C., & Wei, K. (2019) · Biological Research · doi:10.1186/s40659-019-0245-4 · Cited by 87
Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer
Li, Y., Zhao, L., Shi, B., Ma, S., Xu, Z., Ge, Y., Liu, Y., Zheng, D., & Shi, J. (2015) · Scientific Reports · doi:10.1038/srep18648 · Cited by 86
Singh, V. K., Gupta, D., & Arora, R. (2015) · Discoveries · doi:10.15190/d.2015.27 · Cited by 85
MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis
Mu, H., He, Y. H., Wang, S., Yang, S. S., Wang, Y., Nan, C., Bao, Y. F., Xie, Q., & Chen, Y. H. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02217-5 · Cited by 85
Siveen, K. S., Nguyen, A. H., Lee, J. H., Li, F., Singh, S. S., Kumar, A. P., Low, G., Jha, S., Tergaonkar, V, Ahn, K. S., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.422 · Cited by 85
Self-citationSiu, M. K. Y., Jiang, Y., Wang, J., Leung, T. H. Y., Ngu, S., Cheung, A., Ngan, H., & Chan, K. K. L. (2020) · Oncogenesis · doi:10.1038/s41389-020-0209-0 · Cited by 84
Zeng, C., Dong, F., Xu, Y., Li, X., Yuan, J., Yang, Q., Zhou, X., Lu, J., Zhang, C., Han, J., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113795 · Cited by 82
Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance
Yao, S., Yin, Y., Jin, G., Li, D., Li, M., Hu, Y., Feng, Y., Liu, Y., Bian, Z., Wang, X., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3248 · Cited by 82
Yang, Y., Ma, L., Xu, Y., Liu, Y., Li, W., Cai, J., & Zhang, Y. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2675-x · Cited by 80
Yang, T., Li, S., Liu, J., Yin, D., Yang, X., & Tang, Q. (2018) · Cancer Medicine · doi:10.1002/cam4.1405 · Cited by 80
The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma
Chen, X., Tang, F. R., Arfuso, F., Cai, W.-Q., Ma, Z., Yang, J., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom10010066 · Cited by 80
Self-citationQuantitative assessment of telomerase components in cancer cell lines
Akıncılar, S. C., Low, K. C., Liu, C. Y., Yan, T. D., Oji, A., Ikawa, M., Li, S., & Tergaonkar, V. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.035 · Cited by 79
Self-citationHuang, T., Kang, W., Zhang, B., Wu, F., Dong, Y., TONG, J. H. M., Yang, W., Zhou, Y., Zhang, L., Cheng, A. S. L., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0493-7 · Cited by 79
LncRNA SNHG5: A new budding star in human cancers
Li, Y.-H., Hu, Y., Wang, S.-C., Yang, L., & Chen, D. (2020) · Gene · doi:10.1016/j.gene.2020.144724 · Cited by 79
miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer
Jiang, L., Yu, L., Zhang, X., Lei, F., Wang, L., Liu, X., Wu, S., Zhu, J., Wu, G., Cao, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1770 · Cited by 77
Li, F., Shanmugam, M. K., Siveen, K. S., Wang, F., Ong, T. H., Loo, S. Y., Swamy, M. M. M., Mandal, S., Kumar, A. P., Goh, B. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2881 · Cited by 77
Self-citationmiR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer
Wa, Q., Huang, S., Pan, J., Tang, Y., He, S., Fu, X., Peng, X., Chen, X., Yang, C., Ren, D., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.008 · Cited by 76
Keerthy, H. K., Mohan, C. D., Siveen, K. S., Fuchs, J. E., Rangappa, S., Sundaram, M. S., Li, F., Girish, K. S., Sethi, G., Basappa, B., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.593855 · Cited by 76
Self-citationSantolla, M. F., Lappano, R., Cirillo, F., Rigiracciolo, D. C., Sebastiani, A., Abonante, S., Tassone, P., Tagliaferri, P., Martino, M. T. D., Maggiolini, M., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0767-6 · Cited by 75
Zuo, H. X., Jin, Y., Wang, Z., Li, M. Y., Zhang, Z. H., Wang, J. Y., Xing, Y., Ri, M., Jin, C. H., Xu, G. H., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112835 · Cited by 74
miR-552 promotes ovarian cancer progression by regulating PTEN pathway
Zhao, W., Han, T., Li, B., Ma, Q., Yang, P., & Li, H. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0589-y · Cited by 74
Upregulation of lncRNA GAS5 inhibits the growth and metastasis of cervical cancer cells
Yang, W., Xu, X., Li, H., Wang, Q., Huang, J., & Jiang, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28926 · Cited by 73
miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα
He, X., Wang, C., & Liu, Z. (2019) · BMC Cancer · doi:10.1186/s12885-018-5245-1 · Cited by 72
Yu, J., Shi, L., Lin, W., Lu, B., & Zhao, Y. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113745 · Cited by 72
Wang, C., Ke, S., Li, M., Lin, C., Liu, X., & Pan, Q. (2019) · Molecular Genetics and Genomics · doi:10.1007/s00438-019-01620-5 · Cited by 72
A role for IκB kinase 2 in bipolar spindle assembly
Irelan, J. T., Murphy, T. J., DeJesus, P., Teo, H., Xu, D., Gómez-Ferrería, M. A., Zhou, Y., Miraglia, L. J., Rines, D. R., Verma, I. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706493104 · Cited by 70
Self-citationZuo, C., Hong, Y., Qiu, X., Yang, D., Liu, N., Sheng, X., Zhou, K., Tang, B., Xiong, S., Ma, M., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2018.02.006 · Cited by 70
Tian, M., Tian, D., Qiao, X., Li, J., & Zhang, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28715 · Cited by 69
Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma
Neelgundmath, M., Dinesh, K. R., Mohan, C. D., Li, F., Dai, X., Siveen, K. S., Paricharak, S., Mason, D. J., Fuchs, J. E., Sethi, G., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.12.065 · Cited by 68
Self-citationCurrent Insights to Regulation and Role of Telomerase in Human Diseases
Ozturk, M., Li, Y., & Tergaonkar, V. (2017) · Antioxidants · doi:10.3390/antiox6010017 · Cited by 67
Self-citationLiao, X., Gao, Y., Huang, S., Chen, Z., Sun, L., Liu, J., Chen, H., Yu, L., Zhang, J., & Lin, L. (2019) · Phytotherapy Research · doi:10.1002/ptr.6392 · Cited by 66
Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1
Xu, X., Li, Y., Bharath, S. R., Ozturk, M. B., Bowler, M. W., Loo, B. Z. L., Tergaonkar, V., & Song, H. (2018) · Nature Communications · doi:10.1038/s41467-018-05644-0 · Cited by 65
Self-citationWu Mei Wan attenuates CAC by regulating gut microbiota and the NF-kB/IL6-STAT3 signaling pathway
Jiang, F., Liu, M., Wang, H., Shi, G., Chen, B., Chen, T., Yuan, X., Zhu, P., Zhou, J., Wang, Q., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109982 · Cited by 64
Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer
Liu, Z., Zhu, W., Kong, X., Chen, X., Sun, X., Zhang, W., & Zhang, R. (2019) · Oncology Reports · doi:10.3892/or.2019.7294 · Cited by 64
Lymphatic endothelial cells support tumor growth in breast cancer
Lee, E., Pandey, N. B., & Popel, A. S. (2014) · Scientific Reports · doi:10.1038/srep05853 · Cited by 62
LncRNA SNHG15: A new budding star in human cancers
Shuai, Y., Ma, Z., Lu, J., & Feng, J. (2019) · Cell Proliferation · doi:10.1111/cpr.12716 · Cited by 62
Zhao, C., Zhao, Q., Zhang, C., Wang, G., Yao, Y., Huang, X., Zhan, F., Zhu, Y., Shi, J., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04172-z · Cited by 61
Zhang, X., Ren, D., Wu, X., Lin, X., Ye, L., Lin, C., Wu, S., Zhu, J., Peng, X., & Song, L. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.01.004 · Cited by 61
MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8
Mou, T., Xie, F., Zhong, P., Hua, H., Lai, L., Yang, Q., & Wang, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.121 · Cited by 61
Wu, D., Liu, J., Chen, J., He, H., Ma, H., & Lv, X. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15213089759999 · Cited by 61
HMGB1 was negatively regulated by HSF1 and mediated the TLR4/MyD88/NF-κB signal pathway in asthma
Shang, L., Wang, L., Shi, X., Wang, N., Zhao, L., Wang, J., & Liu, C. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117120 · Cited by 61
Li, H., Mou, Q., Li, P., Yang, Z., Wang, Z., Niu, J., Liu, Y., Sun, Z., Lv, S., Zhang, B., et al. (2019) · Journal of Cancer · doi:10.7150/jca.30596 · Cited by 61
Jamieson, N. B., Mohamed, M., Oien, K. A., Foulis, A. K., Dickson, E. J., Imrie, C. W., Carter, C. R., McKay, C. J., & McMillan, D. C. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2370-y · Cited by 60
Gu, Y., Liu, H., Kong, F., Ye, J., Jia, X., Zhang, Z., Li, N., Yin, J., Zheng, G., & He, Z. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0834-z · Cited by 59
lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma
Tang, G., Luo, L., Zhang, J., Zhai, D., Huang, D., Yin, J., Zhou, Q., Zhang, Q., & Zheng, G. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.047 · Cited by 59
miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer
Xia, J., Cao, T., Ma, C., Shi, Y., Sun, Y., Wang, Z. P., & Ma, J. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.08.012 · Cited by 58
Eguchi, R., & Wakabayashi, I. (2020) · Oncology Reports · doi:10.3892/or.2020.7580 · Cited by 58
Yu, X., Chen, Y., Tian, R., Li, J., Li, H., Lv, T., & Yao, Q. (2017) · Oncology Letters · doi:10.3892/ol.2017.6324 · Cited by 58
Wang, T., Xu, X., Xu, Q., Ren, J., Shen, S., Fan, C., & Hou, Y. (2016) · Oncogene · doi:10.1038/onc.2016.468 · Cited by 57
Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis
Han, B., Ge, Y., Cui, J., & Liu, B. (2020) · Bioengineered · doi:10.1080/21655979.2020.1757224 · Cited by 57
MiR-449a promotes breast cancer progression by targeting CRIP2
Shi, W., Bruce, J. P., Lee, M., Yue, S., Rowe, M. R., Pintilie, M., Kogo, R., Bissey, P.-A., Fyles, A., Yip, K. W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7753 · Cited by 57
Li, Y., Lin, Z., Chen, B., Chen, S., Jiang, Z., Zhou, T., Hou, Z., & Wang, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.058 · Cited by 57
miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6
Liu, X., Liu, B., Li, R., Wang, F., Wang, N., Zhang, M., Bai, Y., Wu, J. C., Liu, L., Han, D., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00847 · Cited by 57
Sanches, J. G. P., Xu, Y., Yabasin, I. B., Li, M., Lü, Y., Xiu, X., Wang, L., Mao, L., Shen, J., Wang, B., et al. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.02.024 · Cited by 57
Pan, Y., Zhang, Y., Yuan, J., Ma, X., Zhao, Y., Li, Y., Li, F., Gong, X., Zhao, J., Tang, H., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6724 · Cited by 57
Sun, T., Gao, J., Han, D., Shi, H., & Liu, X. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1667454 · Cited by 55
Ohta, K., Ohigashi, M., Naganawa, A., Ikeda, H., Sakai, M., Nishikawa, J., Imagawa, M., Osada, S., & Nishihara, T. (2007) · Biochemical Journal · doi:10.1042/bj20061194 · Cited by 54
Zhao, X., Ma, L., Dai, L., Zuo, D., Li, X., Zhu, H., & Xu, F. (2020) · Oncology Reports · doi:10.3892/or.2020.7631 · Cited by 54
Ning, N., Liu, S., Liu, X., Tian, Z., Jiang, Y., Yu, N., Tan, B., Feng, H., Feng, X., & Zou, L. (2020) · Journal of Cancer · doi:10.7150/jca.38624 · Cited by 54
miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα
Luo, M., Ding, L., Li, Q., & Yao, H. (2017) · Breast Cancer · doi:10.1007/s12282-017-0756-1 · Cited by 54
Wu, Y., Si, Y., Xiang, Y., Zhou, T., Liu, X., Wu, M., Li, W., Zhang, T., Xiang, K., Zhang, L., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108285 · Cited by 53
Guo, Q., Jing, F.-J., Xu, W., Li, X., Li, X., Sun, J., Xing, X., Zhou, C., & Jing, F. (2019) · Aging · doi:10.18632/aging.102598 · Cited by 53
Zhou, K., Song, B., Wei, M., Fang, J., & Xu, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01483-6 · Cited by 52
Tong, W., Guo, J., & Yang, C. (2020) · Bioscience Reports · doi:10.1042/bsr20200259 · Cited by 52
Gong, Y., Wan, J., Zou, W., Lian, G., Qin, J., & Wang, Q. (2019) · Future Oncology · doi:10.2217/fon-2018-0497 · Cited by 52
Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis
Liu, B., Liu, Z., Chen, S., Ki, M., Erickson, C., Reis-Filho, J. S., Durham, B. H., Chang, Q., de Stanchina, E., Sun, Y., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138315 · Cited by 51
Yang, C., Shi, S., Su, Y., Tong, J., & Li, L. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15708 · Cited by 51
Yan, Z., Xiao, Y., Chen, Y., & Luo, G. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152784 · Cited by 51
Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal
Huang, X., Teng, Y., Yang, H., & Ma, J.-C. (2016) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20165717 · Cited by 51
Zhang, Y., Jin, Y., Li, C., Wang, X., Dong, Y., Shen, X., & Zhang, X. (2019) · Journal of Inflammation · doi:10.1186/s12950-019-0226-y · Cited by 51
Zhu, G., Cheng, Z., Huang, Y., Zheng, W., Yang, S., Lin, C., & Ye, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116831 · Cited by 50
Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis
Huang, S., Xue, P., Han, X., Zhang, C., Yang, L., Liu, L., Wang, X., Li, H. R., Fu, J., & Zhou, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2621-y · Cited by 50
Cited by
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
Self-citationNF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., Fakhri, F., Hashemi, M., Hushmandi, K., Ashrafizadeh, M., Zarrabi, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112563 · Cited by 400
Self-citationRetractedMirzaei, S., Saghari, S., Bassiri, F., Raesi, R., Zarrabi, A., Hushmandi, K., Sethi, G., & Tergaonkar, V. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30759 · Cited by 243
“The lncRNAs can reduce miRNA expression via sponging (Ashrafizadeh, Zarrabi, Hushmandi, Hashemi et al., 2020).”
BackgroundInfluentialSelf-citationHashemi, M., Zandieh, M. A., Talebi, Y., Rahmanian, P., Shafiee, S. S., Nejad, M. M., Babaei, R., Sadi, F. H., Rajabi, R., Abkenar, Z. O., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114392 · Cited by 117
Self-citationRetracted
Metadata
- Authors
- Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Ranjbar, A., Seyed Saleh, S. H., Bagherian, M., Sharifzadeh, S. O., Hushmandi, K., Liskova, A., Kubatka, P., Makvandi, P., Tergaonkar, V., Kumar, A. P., Ashrafizadeh, M., & Sethi, G.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 509
- Pages
- 63-80
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W3149058386
- Cited by
- 224
- References
- 289
- FWCI
- 16.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.